Pharmaceutical giants Daiichi Sankyo and Merck & Co., known globally as MSD, have officially announced the voluntary withdrawal of their…
Read More

Pharmaceutical giants Daiichi Sankyo and Merck & Co., known globally as MSD, have officially announced the voluntary withdrawal of their…
Read More
Bayer has achieved a significant regulatory milestone with the US Food and Drug Administration (FDA) granting accelerated approval for its…
Read More
Just days after finalizing a monumental $10.6 billion acquisition of Nuvalent, a move that significantly bolsters its oncology pipeline, GlaxoSmithKline…
Read More
The fundamental understanding of human physiology has undergone a significant shift following a groundbreaking study by researchers at the University…
Read More
The biological understanding of human hematopoiesis—the process through which the body manufactures blood cells—has undergone a fundamental shift following a…
Read More
The American Society of Clinical Oncology (ASCO) 2026, held from May 29 to June 2, 2026, served as a critical…
Read More
Immunotherapy has fundamentally reshaped the landscape of lung cancer treatment, offering a beacon of hope and significantly improving patient prognoses.…
Read More
The annual American Society of Clinical Oncology (ASCO) congress, a cornerstone event for the global oncology community, convened in Chicago,…
Read More
The landscape of lung cancer treatment has undergone a significant transformation with the advent of immunotherapy, particularly checkpoint inhibitors, offering…
Read More
For more than a century, medical textbooks and clinical practices have operated under the firm consensus that the bone marrow…
Read More